Tilray Inc sell tamam
Summary
This prediction ended on 29.10.18 with a price of €102.66. tamam correctly predicted massive losses of -45.09% for Tilray Inc. tamam has 50% into this predictionTilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tilray Inc | -14.105% | -14.105% | -78.620% | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by tamam for this prediction
In the thread Tilray Inc diskutieren
The Tilray Bubble Is Bound To Burst
The valuation of TLRY, based on Bloomberg’s shares outstanding number of 76.48 million and the recent prices of $155, is an astounding $11.9 billion market cap. The company had $17.5 million in sales the first half of 2018, meaning shares trade approximately 340 times this year’s sales.
There is a chance that TLRY really does become a global cannabis supplier. As I discussed above, I view this to be highly unlikely but if it really were to happen, then TLRY would have the growth potential to
support its lofty valuation. That said, I need to see results before believing - at these prices, investors should be instead asking themselves why they believe TLRY will become a global supplier.